Clinical Trial Update: Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study comparing the insulin PK profile of Biphasic Insulin Aspart 70 with Biphasic Insulin Aspart 30 in healthy volunteers. The trial was sponsored by N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Biphasic insulin aspart 70 (insulin aspart, biphasic 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED